THE INFLUENCE OF 2-CHLORODEOXYADENOSINE, CYTOSINE-ARABINOSIDE AND DOXORUBICIN ON ACUTE MYELOID-LEUKEMIA CLONOGENIC CELLS (L-CFU) PROLIFERATION

被引：0
|
作者：
SAWINSKI, K [1 ]
HANSZ, J [1 ]
KOZLOWSKASKRZYPCZAK, M [1 ]
机构：
[1] KAROL MARCINKOWSKI UNIV MED SCI,DEPT HEMATOL,POZNAN,POLAND
来源：
EXPERIMENTAL HEMATOLOGY | 1995年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：927 / 927
页数：1
相关论文
共 50 条
  • [31] MITOXANTRONE AND CYTOSINE-ARABINOSIDE AS 1ST LINE THERAPY IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    HUTCHINSON, RM
    WINFIELD, DA
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (03) : 416 - 417
  • [32] LOW-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS)
    WEH, HJ
    ZSCHABER, R
    HOSSFELD, DK
    BLUT, 1984, 48 (04): : 239 - 242
  • [33] MITOXANTRONE AND CYTOSINE-ARABINOSIDE AS 1ST-LINE THERAPY IN ELDERLY PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    YIN, JAL
    JOHNSON, PRE
    DAVIES, JM
    FLANAGAN, NG
    GORST, DW
    LEWIS, MJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (03) : 415 - 420
  • [34] TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA (AML) WITH MITOXANTRONE AND CYTOSINE-ARABINOSIDE - EXPERIENCE AFTER ONE YEAR
    DHARMASENA, F
    CATOVSKY, D
    GALTON, DAG
    GOLDMAN, JM
    MARCUS, RE
    SLOCOMBE, G
    NEWLAND, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 813 - 814
  • [35] STRUCTURAL-ANALYSIS OF THE DEOXYCYTIDINE KINASE GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND RESISTANCE TO CYTOSINE-ARABINOSIDE
    FLASSHOVE, M
    STRUMBERG, D
    AYSCUE, L
    MITCHELL, BS
    TIRIER, C
    HEIT, W
    SEEBER, S
    SCHUTTE, J
    LEUKEMIA, 1994, 8 (05) : 780 - 785
  • [36] ACLARUBICIN PLUS CYTOSINE-ARABINOSIDE VERSUS DAUNORUBICIN PLUS CYTOSINE-ARABINOSIDE IN PREVIOUSLY UNTREATED PATIENTS WITH ACUTE MYELOID-LEUKEMIA - A DANISH NATIONAL PHASE-III TRIAL
    HANSEN, OP
    PEDERSENBJERGAARD, J
    ELLEGAARD, J
    BRINCKER, H
    BOESEN, AM
    CHRISTENSEN, BE
    DRIVSHOLM, A
    HIPPE, E
    JANS, H
    JENSEN, KB
    KILLMANN, SA
    JENSEN, MK
    KARLE, H
    LAURSEN, B
    NIELSEN, JB
    NISSEN, NI
    THORLING, K
    LEUKEMIA, 1991, 5 (06) : 510 - 516
  • [37] EFFECT OF MEDIUM CONDITIONED BY ACUTE MYELOID-LEUKEMIA CELLS ON NORMAL MARROW COLONY-FORMING ABILITY AND SENSITIVITY TO CYTOSINE-ARABINOSIDE
    GORDON, MY
    DOUGLAS, IDC
    BLACKETT, NM
    EUROPEAN JOURNAL OF CANCER, 1978, 14 (06) : 661 - 665
  • [38] INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID-LEUKEMIA USING A REGIME CONTAINING CYTOSINE-ARABINOSIDE, DAUNORUBICIN AND ETOPOSIDE
    LIANG, R
    CHIU, E
    CHAN, TK
    TODD, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (05) : 380 - 382
  • [39] PRONOSTIC VALUE OF INVITRO UPTAKE AND RETENTION OF CYTOSINE-ARABINOSIDE (ARA-C) IN ACUTE MYELOID-LEUKEMIA (AML)
    MARIE, JP
    ZITTOU, R
    DELANIAN, S
    SUBERVILLE, AM
    THEVENIN, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 208 - 208
  • [40] SALVAGE CHEMOTHERAPY CONTAINING MODERATE-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE FOR RELAPSED AND RESISTANT ACUTE MYELOID-LEUKEMIA
    LIANG, R
    CHIU, E
    CHAN, TK
    TODD, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 28 (01) : 74 - 76
12345